9 Meters Biopharma Inc
(NMTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,453 | 2,970 | 152 | 42 | 119 |
| Receivables | 856 | 928 | 1,038 | 348 | 644 |
| Inventories | 1,105 | 1,789 | 1,029 | 491 | 633 |
| TOTAL | $4,033 | $6,127 | $2,273 | $939 | $1,537 |
| Non-Current Assets | |||||
| Intangibles | 2,417 | 2,450 | 2,483 | 2,515 | 2,548 |
| Other Non-Current Assets | 14 | 14 | 1,168 | 860 | 633 |
| TOTAL | $2,431 | $2,464 | $3,651 | $3,375 | $3,181 |
| Total Assets | $6,464 | $8,591 | $5,924 | $4,314 | $4,718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 322 | 147 | 215 |
| Accounts payable and accrued liabilities | 312 | 388 | 2,000 | 2,090 | 1,531 |
| Accrued Expenses | 1,786 | 3,275 | 3,628 | 3,041 | 3,311 |
| Other current liabilities | 1,840 | 1,840 | 1,825 | 1,850 | 1,850 |
| TOTAL | $3,976 | $5,541 | $12,167 | $11,331 | $10,412 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,976 | $5,541 | $12,167 | $11,331 | $10,412 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40 | 37 | 37 | 37 | N/A |
| Common Shares | 1 | N/A | N/A | N/A | N/A |
| Retained earnings | -32,088 | -30,830 | -28,996 | -27,756 | -25,875 |
| TOTAL | $2,488 | $3,050 | $-6,243 | $-7,017 | $-5,694 |
| Total Liabilities And Equity | $6,464 | $8,591 | $5,924 | $4,314 | $4,718 |